Torus Biosystems is developing the next generation of POC molecular diagnostics for syndromic infectious diseases based on the novel integration of qPCR and microarray technologies that enable detection and quantification of DNA in under 30 minutes.

Analytics

Biotechnology

Torus Biosystems

Torus Biosystems' headquarters in Cambridge, MA, United States

Dmitriy Khodakov

Yalei Wu

Peng Yin

David R Walt

Shawn Marcell

The leadership team at Torus Biosystems is made up of experienced professionals from a variety of industries and educational backgrounds. These include the Vice President of Strategy and Business Development from Diagnostic Systems at BD, the Vice President of Business Development at Hologic, the Senior Director of Corporate Development at Cell Signaling Technology, and the Vice President of Technology Assessment at Ortho Clinical Diagnostics. The team also includes the Chief Financial Officer from ReadCoor, Inc. (acquired by 10x Genomics), the Vice President of Finance from Metamark Genetics, Inc., the Vice President and Controller from Wingate Healthcare, and the Corporate Controller / Director of Finance from National Dentex, LLC. Additionally, the team has members with experience in human resources, including the Vice President of Human Resources from TransMedics, Inc., the Head of Global Talent Management from Aegerion Pharmaceuticals, and Human Resources from Broad Institute of MIT and Harvard. Finally, the team includes members with experience in product management, including the Director of Product Management from Glaukos Corporation and the Director, Product Management from T2 Biosystems.

Torus Biosystems

Org chart

Board & advisors

Teams

Leadership Team

Offices

Torus Biosystems

Org chart

Board & advisors

Teams

Leadership Team

Offices

Related companies